Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer August 11, 2020
MPM and Longwood-backed Werewolf Therapeutics Grabs $56 Million to Take Tumors by Night November 20, 2019
Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines November 20, 2019
